NALOX™/NALOC™

On March 29, 2019, all OTC brands were divested to Advantice Health. See press release

DESCRIPTION

Nalox/Naloc is a solution applied to the damaged nail. Nalox/Naloc is patented, and is based on proven compounds. Nalox/Naloc is available without prescription under the trademark Emtrix® in some countries and as Kerasal Nail® in USA. Its effect and safety have been documented in several clinical trials including more than 600 patients. Nalox/Naloc has a unique rapid mechanism of action and has demonstrated strong competitive results, including visible improvements already within 2-4 weeks. The Nalox™/ Naloc™ brands are owned by Meda AB.

PUBLICATIONS

• Emtestam et al. Mycoses 2012, Vol 55:532-540. Treatment of distal subungual onychomycosis with a topical preparation of urea, propylene glycol and lactic acid: results of a 24-week, double-blind, placebo-controlled study.
• Faergemann et al. Journal of Cosmetics, Dermatological Sciences and Applications 2011, Vol 1:59-63. Early and Visible Improvements after Application of K101 in the Appearance of Nails Discoloured and Deformed by Onychomycosis.
• Hultenby et al. Mycoses 2014, Vol 57:630-638. The Effect of K101 Nail Solution on Trichophyton rubrum and Candida albicans growth and ultrastructure.